CVS Caremark Corp. EVP Helena Foulkes Sells 47,568 Shares (CVS)
CVS Caremark Corp. (NYSE:CVS) EVP Helena Foulkes sold 47,568 shares of the company’s stock on the open market in a transaction dated Monday, September 9th. The stock was sold at an average price of $58.65, for a total transaction of $2,789,863.20. Following the transaction, the executive vice president now directly owns 7,897 shares in the company. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
CVS has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of CVS Caremark Corp. (NYSE:CVS) in a research note to investors on Wednesday, August 28th. They now have a $61.00 price target on the stock. Separately, analysts at Barclays Capital raised their price target on shares of CVS Caremark Corp. (NYSE:CVS) from $67.00 to $69.00 in a research note to investors on Thursday, August 8th. Finally, analysts at ISI Group cut their price target on shares of CVS Caremark Corp. (NYSE:CVS) from $67.50 to $66.50 in a research note to investors on Wednesday, August 7th. They now have a “buy” rating on the stock.
Five analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $62.89.
CVS Caremark Corp. (NYSE:CVS) traded up 0.64% during mid-day trading on Wednesday, hitting $59.60. The stock had a trading volume of 4,281,270 shares. CVS Caremark Corp. has a 1-year low of $44.33 and a 1-year high of $62.36. The stock has a 50-day moving average of $59.51 and a 200-day moving average of $57.75. The company has a market cap of $73.129 billion and a price-to-earnings ratio of 17.57.
CVS Caremark Corp. (NYSE:CVS) last announced its earnings results on Tuesday, August 6th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.01. The company had revenue of $31.25 billion for the quarter, compared to the consensus estimate of $31.13 billion. During the same quarter in the previous year, the company posted $0.81 earnings per share. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. On average, analysts predict that CVS Caremark Corp. will post $3.96 earnings per share for the current fiscal year.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.